{"title":"老年人和孕妇新冠肺炎病例中的C反应蛋白：一种旧标志物的新作用","authors":"E. Ali, D. Salman, Wassan Nori","doi":"10.4103/mj.mj_54_22","DOIUrl":null,"url":null,"abstract":"The clinical characteristics and prognosis of high-risk groups, including elderly and pregnant women, may vary according to the overall susceptibility of novel coronavirus. For that, numerous researchers worldwide have concentrated their efforts on finding a trustworthy biomarker that can determine the severity, prognosis, and survival of those affected. C-reactive protein (CRP), an inflammatory biomarker that showed higher levels in coronavirus 2019 (COVID-19) cases, underlay inflammation degree and was used to gauge the severity of COVID-19. In this review, we discuss whether CRP might have other uses in COVID-19 cases besides predicting the severity and the clinical outcomes among vulnerable risk groups. Doctors must analyze CRP levels along with the period of illness to identify those liable for rapid progress and be able to categorize case severity to guide the clinical decision to improve prognosis.","PeriodicalId":33069,"journal":{"name":"mjl@ lmstnSry@ lTby@","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"C-reactive protein in elderly and pregnant COVID-19 cases: A new role for an old marker\",\"authors\":\"E. Ali, D. Salman, Wassan Nori\",\"doi\":\"10.4103/mj.mj_54_22\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The clinical characteristics and prognosis of high-risk groups, including elderly and pregnant women, may vary according to the overall susceptibility of novel coronavirus. For that, numerous researchers worldwide have concentrated their efforts on finding a trustworthy biomarker that can determine the severity, prognosis, and survival of those affected. C-reactive protein (CRP), an inflammatory biomarker that showed higher levels in coronavirus 2019 (COVID-19) cases, underlay inflammation degree and was used to gauge the severity of COVID-19. In this review, we discuss whether CRP might have other uses in COVID-19 cases besides predicting the severity and the clinical outcomes among vulnerable risk groups. Doctors must analyze CRP levels along with the period of illness to identify those liable for rapid progress and be able to categorize case severity to guide the clinical decision to improve prognosis.\",\"PeriodicalId\":33069,\"journal\":{\"name\":\"mjl@ lmstnSry@ lTby@\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"mjl@ lmstnSry@ lTby@\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4103/mj.mj_54_22\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"mjl@ lmstnSry@ lTby@","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/mj.mj_54_22","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
C-reactive protein in elderly and pregnant COVID-19 cases: A new role for an old marker
The clinical characteristics and prognosis of high-risk groups, including elderly and pregnant women, may vary according to the overall susceptibility of novel coronavirus. For that, numerous researchers worldwide have concentrated their efforts on finding a trustworthy biomarker that can determine the severity, prognosis, and survival of those affected. C-reactive protein (CRP), an inflammatory biomarker that showed higher levels in coronavirus 2019 (COVID-19) cases, underlay inflammation degree and was used to gauge the severity of COVID-19. In this review, we discuss whether CRP might have other uses in COVID-19 cases besides predicting the severity and the clinical outcomes among vulnerable risk groups. Doctors must analyze CRP levels along with the period of illness to identify those liable for rapid progress and be able to categorize case severity to guide the clinical decision to improve prognosis.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
